/Investor DB

HARPER COURT VENTURES — 2025 Investments

2 investments dated 2025 · listed companies and verified rows first · show all

Orisdxorisdx.cominMay 2025

OrisDX develops a non-invasive salivary-rinse DNA test called Oro Lesion to detect early markers of oral cavity squamous cell carcinoma in adults with indeterminate oral lesions.

BiotechDigital HealthMedical DevicesChicago, US

Harald Steltzer(Chief Executive Officer)inPatrick Conniff(Executive Officer)inEvgeny Izmchenko(Director)Nishant Agrawal(Chair & Co-Founder)inEvgeny Izumchenko, PhD(Co-Founder)

PartnerKarthee Madasamy· solo GP

Co-investorsAngel Physicians Fund

PSI Quantumpsiquantum.comin𝕏May 2025

PsiQuantum builds fault-tolerant quantum computers using photonic qubits and semiconductor manufacturing processes.

Deep TechHardwareQuantum ComputingSemiconductorsMoreton Bay, AU

Prof. Terry Rudolph(Co-founder & Chief Architect)Dr. Pete Shadbolt(Co-founder & Chief Scientific Officer)inProf. Mark Thompson(Co-founder & Chief Technology Officer)Jeremy O'Brien(Co-founder & Executive Chairman)inVictor Peng(Chief Executive Officer)inMark Thompson(Founder)

PartnerKarthee Madasamy· solo GP

Co-investorsAtomicoBlackbird VenturesC4 VenturesCold Start VenturesFOG VenturesFounders Fund+40 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.